Due to widespread photo-editing technology through web applications such as Facetune and Snapchat, the idea of physical "perfection" has become an epidemic among social media users.
WHO officials have not yet pinpointed the strain of Ebola that is responsible for the death of 20 people and has infected four more, including two health workers. They are uncertain whether it could be the Zaire, Sudan or Bundibugyo strain.
AstraZeneca and MSD's neurofibromatosis type 1 (NF1) drug, selumetinib, a MEK 1/2 inhibitor, receives orphan designation by the EMA.
A longitudinal cohort study published in the Clinical Gastroenterology and Hepatology revealed that non-alcoholic fatty liver disease (NAFLD) patients who consumed modest amounts of alcohol had notably low improvement in steatosis and significantly lower chances of recovery of non-alcoholic steatohepatitis (NASH), contrasted with non-drinkers.
Machine learning can forecast whether a cystic fibrosis (CF) patient should be sent for a lung transplant with a 35% enhancement in accuracy over current methods. These were the results of collaborated research done between Oxford University’s Alan Turing Institute and the Cystic Fibrosis Trust.
WebMD, an Internet Brands company, announced its purchase of Vitals Consumer Services Division from Mdx Medical in a period of two months since its earlier acquisition.
Scientists at the University of Texas in Austin have found a solution to tackle the off-centered effects of the gene editing system CRISPR-Cas9, a potential treatment for diseases caused by genetic aberrations. They suggest replacing Cas9 with a different protein, Cas12a.
Have you gone out and left the television on? Have you ever forgot to buy the item for which you went shopping for? These are examples of prospective memory failure, which could be an early sign of Alzheimer's disease.
Angiostrongyliasis or more commonly known as ‘rat lungworm disease’ has been linked with the consumption of raw vegetables infected with the larvae of the parasite Angiostrongylus cantonensis in the continental U.S.
GE Healthcare has launched a second phase III (AURORA) clinical trial for using Flurpiridaz 18F Injection in positron-emission tomography (PET) myocardial perfusion imaging (MPI), in order to detect coronary artery disease (CAD).
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.